Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic

Biologics in Inflammatory and Immunomediated Arthritis

(2018) Michele M. Luchetti et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease

(2018) Michele Maria Luchetti et al.   JOURNAL OF RHEUMATOLOGY

Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis

(2017) P. Gisondi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriatic Arthritis

(2017) Christopher T. Ritchlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

(2017) Michele Maria Luchetti et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature

(2016) Jordi Gratacos-Masmitja et al.   ADVANCES IN THERAPY

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1

(2016) Philip J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care

(2016) Maren C. Karreman et al.   RHEUMATOLOGY

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

(2016) Laura C. Coates et al.   Arthritis & Rheumatology

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

(2015) L Gossec et al.   ANNALS OF THE RHEUMATIC DISEASES

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

(2015) Philip J. Mease et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review

(2015) Tatiana Cobo-Ibáñez et al.   RHEUMATOLOGY INTERNATIONAL

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

(2014) Arthur Kavanaugh et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriasis and psoriatic arthropathy multidisciplinary clinic at Basurto University Hospital: 2 years of experience

(2014)   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

(2013) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)

(2013) L.C. Coates et al.   BRITISH JOURNAL OF DERMATOLOGY

Limitations in Screening Instruments for Psoriatic Arthritis: A Comparison of Instruments in Patients with Psoriasis

(2013) J. A. WALSH et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

(2013) Iain B McInnes et al.   LANCET

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

(2013) Laura C. Coates et al.   RHEUMATOLOGY

High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires

(2012) Muhammad Haroon et al.   ANNALS OF THE RHEUMATIC DISEASES

Sensitivity and specificity of the Classification of Psoriatic Arthritis criteria in early psoriatic arthritis

(2012) Laura C. Coates et al.   ARTHRITIS AND RHEUMATISM

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

(2012) Gabrielle H. Kingsley et al.   RHEUMATOLOGY

Assessment and management of psoriasis: summary of NICE guidance

(2012) E. Samarasekera et al.   BMJ-British Medical Journal

Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic

(2011) Nicole F. Velez et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

(2010) M. Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people

(2009) Fausto Salaffi et al.   Health and Quality of Life Outcomes

Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey

(2009) MA Radtke et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

(2008) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES